Winton Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-18,951
| Closed | -$2.03M | – | 969 |
|
|
2021
Q4 | $2.03M | Sell |
18,951
-10,951
| -37% | -$1.17M | 0.12% | 223 |
|
|
2021
Q3 | $3.07M | Buy |
29,902
+9,731
| +48% | +$1M | 0.17% | 99 |
|
|
2021
Q2 | $1.77M | Buy |
20,171
+3,233
| +19% | +$284K | 0.1% | 231 |
|
|
2021
Q1 | $1.65M | Buy |
16,938
+1,703
| +11% | +$166K | 0.09% | 208 |
|
|
2020
Q4 | $1.71M | Sell |
15,235
-16,861
| -53% | -$1.89M | 0.12% | 167 |
|
|
2020
Q3 | $2.98M | Buy |
+32,096
| New | +$2.98M | 0.1% | 332 |
|
|
2019
Q2 | – | Sell |
-3,077
| Closed | -$246K | – | 1135 |
|
|
2019
Q1 | $246K | Buy |
+3,077
| New | +$246K | ﹤0.01% | 880 |
|
|
2018
Q3 | – | Sell |
-3,170
| Closed | -$201K | – | 1019 |
|
|
2018
Q2 | $201K | Sell |
3,170
-1,693
| -35% | -$107K | 0.01% | 986 |
|
|
2018
Q1 | $446K | Buy |
+4,863
| New | +$446K | 0.01% | 828 |
|